Last reviewed · How we verify

NCT03432754: HEALTH

Health Education and Lifestyle Training in Older Adults

Completed NA Last updated 14 February 2018
What this trial tests

NA trial testing Mindfulness-Based Attention Training in Older Adults in 74 participants. Completed in 29 April 2015.

Timeline
20 October 2014
Primary endpoint
29 April 2015
29 April 2015

Quick facts

Lead sponsorOhio State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment74
Start date20 October 2014
Primary completion29 April 2015
Estimated completion29 April 2015

Drugs / interventions tested

Conditions studied

Sponsor

Ohio State University

Who can join

Adults 60 to 74, any sex, with Older Adults. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators conducted a mindfulness training intervention in older adults aimed at examining the effects of brief mindfulness training on mind wandering as well as the cognitive and affective functioning of older adults. Individuals completed pre- and post-assessments of mind wandering and cognitive functioning. Additionally, all participants completed neuropsychological measures and self-report questionnaires.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Psychosocial Correlates of Adherence to Mind-Body Interventions.
    Duraney EJ, Phansikar M, Prakash RS. · · 2025 · PMID 40325320 · DOI 10.1007/s11121-025-01810-1

Verify or expand the search:

Other recruiting trials for Older Adults

Currently open trials in the same condition.

Other Ohio State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03432754.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing